The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in cosmetics to deliver significant skin care longevity benefits to consumers around the world.
The exclusive partnership will accelerate ELC’s focus on transformative product innovation by applying insights from Serpin Pharma’s two decades of anti-inflammatory research, which has yielded proprietary biotech technology demonstrating remarkable efficacy mitigating harmful inflammation and enhancing cell resiliency. Serpin Pharma identified a key portion of a superfamily of proteins called SERPINs (Serine Protease Inhibitors) that enhance the body’s natural ability to heal cells experiencing inflammation. Together, the companies are investigating how this innovative technology, which leverages the body’s innate immune response, can be harnessed to address skin irritation, aging, and sensitivity. Scientific studies are underway to demonstrate how Serpin’s technology can be applied to cosmetic products to rapidly and visibly reduce skin aging and irritation.
“This novel technology will advance our transformative innovation agenda by pushing the boundaries of breakthrough scientific discovery,” said Carl Haney, Executive Vice President, Global Innovation and Research and Development (R&D), The Estée Lauder Companies. “In partnership with Serpin Pharma, we’re exploring powerful new biological pathways and cutting-edge biotech ingredients to rapidly mitigate visible skin irritation and sensitivity for our prestige beauty consumers worldwide.”
“Serpin Pharma was founded on the principles of biomimicry and how nature solves for signs of trauma and injury,” said Cohava Gelber, PhD, MBA, Founder, Executive Chairperson and CEO, Serpin Pharma. “We’re taking a novel approach by tapping into the body’s innate mechanism for resolving inflammation. We are proud to partner with ELC to explore how our powerful biotechnology can be applied to cosmetics and skin care.”
This work builds on ELC’s decades-long leadership in longevity science, biotechnology and fermentation. The company is step-changing innovation by partnering with biotech companies across sectors to commercialize their breakthrough innovations and applying their cutting-edge technologies to developing skin care solutions for consumers. It also reinforces ELC’s commitment to creating transformative product innovation to deliver fast-to-market, on-trend innovation across in-demand subcategories, benefits, and occasions, as part of ELC’s newly unveiled Beauty Reimagined strategic vision.
With R&D and Innovation Centers around the world, ELC's scientists have multidisciplinary expertise ranging from basic science and advanced technologies to the intersections of physics, chemistry, biology, and engineering. ELC R&D has 75 years of formulation authority and is deeply integrated into the scientific community, regularly presenting at leading events, publishing in peer-reviewed journals, and partnering with leading scientists, institutions, and academia across a broad array of sectors.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
About Serpin Pharma, Inc
Serpin Pharma is a trailblazing, clinical-stage pharmaceutical company committed to the development of groundbreaking anti-inflammatory and immune-modulating therapies aimed at effectively treating diseases driven by inflammation. Located in Virginia, the company has engineered a remarkably small, highly selective peptide therapeutic that boasts an astonishing potency—300 times greater than that of its natural counterpart, Alfa-1 Antitrypsin (A1AT), in delivering anti-inflammatory and regenerative effects.
This innovative drug platform by Serpin Pharma not only halts unchecked inflammation without compromising the immune system but also promotes the repair and regeneration of cells and tissues affected by inflammation, injury, or trauma. With thirteen robust patents securing its pipeline technologies, Serpin Pharma stands on the cusp of pioneering breakthroughs that promise to reshape the landscape of therapeutic treatments.
ELC-C
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225925375/en/
Contacts
Alyssa Kressel
akressel@estee.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Binarly Secures Patent for Machine Learning Technique to Optimize Large-Scale Binary Analysis26.2.2025 22:00:00 EET | Press release
Binarly, a leading innovator in software supply chain security, today announced that it has been granted U.S. Patent No. US 12,236,262 B1 for its groundbreaking "Machine Learning Technique for Efficiently Scheduling Tasks for Large-Scale Analysis of Binary Executables." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226827321/en/ U.S. Patent No. US 12,236,262 -- "Machine Learning Technique for Efficiently Scheduling Tasks for Large-Scale Analysis of Binary Executables." The patent, issued on February 25, 2025, covers a novel method for analyzing binary software efficiently by leveraging machine learning to predict peak memory usage and dynamically allocate computing resources. The patented technology extracts features from software packages (like binary executables) using advanced preprocessing techniques and machine learning models trained on extensive datasets generated from monitoring memory usage during analysis. By e
Intersolar Europe: The Time for Hybrid Power Plants Has Come26.2.2025 17:32:00 EET | Press release
The era of hybrid power plants has arrived. By combining solar, wind, and hydropower with smart storage, these plants integrate renewable electricity efficiently into the grid. As the global solar industry gathers at Intersolar Europe, discussions will focus on the latest advancements, regulations, and future prospects of hybrid power plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226015598/en/ Whether Spain, Portugal or Bulgaria: Networked hybrid power plants are being built in many European countries. ©Solar Promotion GmbH Huge hybrid power plants are being built across Europe: Upon completion, a project in Portugal will comprise a 365 megawatt (MW) PV system, a wind farm with 264 MW, a 168 MW battery storage system and a 500 kilowatt (kW) electrolyzer for producing green hydrogen. A project in Spain combines photovoltaics and hydropower in a hybrid power plant. In Bulgaria, a hybrid power plant is under constru
JAPAN Pavilion to Exhibit at One of the World’s Largest Mobile Events, “MWC Barcelona 2025”26.2.2025 17:00:00 EET | Press release
From Monday, March 3 to Thursday, March 6, the JAPAN Pavilion will be exhibiting at "MWC Barcelona 2025" ("MWC"), one of the world's largest mobile-related events, held in Barcelona, Spain. The JAPAN Pavilion has been continuously organized with the support of the Ministry of Internal Affairs and Communications, supporting the global expansion of Japanese companies, particularly local enterprises, SMEs, and startups that possess excellent technological capabilities and are seeking opportunities to build networks and enhance their brand recognition in overseas markets. This year, the ITU Association of Japan will be in charge of its operation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220101856/en/ JAPAN Pavilion (Photo: Business Wire) Featured Exhibitors and Exhibition Content This year, the JAPAN Pavilion will feature 16 companies with cutting-edge ICT technologies tailored for the 5G and Beyond 5G era, including ne
Brightcove Upgrades its OTT Solution, Delivering Cost Savings and Improved Streaming Quality for Media Companies26.2.2025 16:00:00 EET | Press release
Brightcove, the world’s most trusted intelligent video engagement platform company, today introduced its latest update in OTT (over-the-top) services with its newly enhanced Brightcove OTT solution. Through a collaboration with Applicaster, a no-code SaaS platform, Brightcove’s new OTT capabilities make it easier and more affordable for media companies, streamers, sports leagues, and brands to monetize their content, build subscriber and viewer audiences, and scale their business. The revamped Brightcove OTT solution provides differentiated, ‘grow with you’ flexible app experiences, making it an ideal choice for OTT services of any size to launch quickly. With an accelerated design, onboarding, and launch process, Brightcove OTT ensures one of the fastest time-to-revenue processes for streamers. Additionally, the new OTT solution offers a new price structure at a 40% lower entry point while delivering more efficient stream delivery and streaming operations. A significant enhancement in
NTT DATA and Palo Alto Networks Enhance Private 5G Security for Industrial Deployments26.2.2025 15:00:00 EET | Press release
NTT DATA, a global leader in digital business and technology services, today announced a new managed security service powered by Palo Alto Networks industry-leading technologies to enhance private 5G security in industrial and operational technology (OT) environments. Delivered as a turnkey managed service, the innovative offering provides enterprises with a Private 5G network with the visibility and security needed in today’s OT environments. Combining Palo Alto Networks Next-Generation Firewall (NGFW), OT/ IOT subscriptions with NTT DATA’s Private 5G architecture, the new offering empowers clients with improved network visibility, access control and automated threat detection and response capabilities. With Palo Alto Networks NGFW, organizations can apply a Zero Trust security posture, incorporating machine learning (ML) to safely enable only the relevant connections, applications and protocols needed for their network. The NTT DATA Private 5G and Palo Alto Networks offering is easy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom